We are the
Drug Safety Research Unit
The UK’s leading pharmacovigilance and pharmacoepidemiology unit.
Education & Training
Make yourself a prime candidate for the role you aspire to by studying with DSRU.
Institute of Pharmacovigilance Sciences
Evaluations of existing methods and development of new methods in pharmacovigilance.
The DSRU is an independent unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management, Risk Minimisation for over 40 years.
The Unit conducts a broad range of pharmacoepidemiological studies using a variety of study methods and data sources. The DSRU conducts safety and drug utilisation studies and studies to support risk management and risk minimisation. In addition, the DSRU conducts studies and systematic reviews to understand the safety, use and risk-benefit balance of medicines and vaccines using real world data.
The DSRU is also a leading provider of education and training in pharmacovigilance and pharmacoepidemiology. The Drug Safety Research Unit (DSRU), led by Director Professor Saad Shakir, aims to protect patients from undesirable adverse effects of medicines in clinical use.
Professor Saad Shakir
Director
Testimonials
What our stakeholders are saying about us
Aims to protect patients from undesirable adverse effects of medicines in clinical use
I am very satisfied with the work and involvement that DSRU personnel has in the XXX studies. DSRU are very well known and highly regarded in the pharmaceutical industry. The support they have given to XXX is of the highest possible quality. DSRU have the best professionals for data analysis from epi studies and they have proven it again with the XXX project. The quality of work is impeccable.
A pleasure to work with
Highly collaborative and highly ethical, and a pleasure to work with.
It has been a very positive experience working with DSRU.
News & press
Latest news & press releases from DSRU
Pan-European study of Covid vaccine safety published
The DSRU conducted the UK arm of this study which focused on the safety of all Covid-19 vaccines and was...
DSRU attends DIA Europe conference
The DSRU team was delighted to attend the DIA Europe conference in Basel in March 2023 and to promote our...
How we’re leading UK pharmacovigilance
Here at the Drug Safety Research Unit, we are proud to be the UK’s leading pharmacovigilance and pharmacoepidemiology unit. We...
International group redoubles efforts to improve detection of drug side effects
The International Working Group (IWG) on New Developments in Pharmacovigilance has resumed its work in earnest, following an extended break...
Just published: our paper on cases of thrombosis with concurrent thrombocytopenia following AstraZeneca Covid-19 vaccine.
In March 2021, rare signals of unusual clotting with concurrent low platelets began to emerge in people who had received...
Good to be back at ICPE!
The DSRU had a great conference at ICPE (International Conference on Pharmacoepidemiology & Therapeutic Risk Management) in Copenhagen last week....